Previous Close | $196.82 |
AI Value | $160.89 |
Upside potential | -18% |
Align Technology, Inc. is a global medical device company specializing in innovative orthodontic solutions, primarily known for its Invisalign clear aligners and iTero intraoral scanners. The company holds a dominant position in the clear aligner market, with Invisalign accounting for the majority of its revenue. Align operates in over 100 countries, serving both orthodontists and general dentists, and has established a strong brand reputation for its proprietary digital treatment planning platform, ClinCheck. Its competitive advantages include a vast intellectual property portfolio, a direct-to-professional sales model, and a data-driven approach to treatment customization.
Continuous R&D investment in materials science (e.g., SmartTrack aligner material), AI-powered treatment planning, and new products like Invisalign Palatal Expander. Holds 1,000+ patents globally.
Align Technology is well-positioned to benefit from the secular shift toward clear aligners, supported by its technological leadership and scalable platform. However, competition and regulatory risks warrant monitoring. The stock suits growth investors with a 3-5 year horizon, trading at a premium valuation (P/E ~50x) justified by its high margins and market dominance. Near-term volatility may arise from macroeconomic pressures on elective procedures.
Company 10-K filings, earnings transcripts, industry reports (e.g., Straumann, Envista), and第三方市场分析(如Grand View Research)。
Historical valuation data is not available at this time.